Sea Mild Biotechnology Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sea Mild Biotechnology Co Ltd

Watchlist Manager

Watchlist

Price: 8.4 TWD -1.75%

Market Cap: NT$162.2m

S	Sea Mild Biotechnology Co Ltd TPEX:7516	TW
E	Enzo Biochem Inc SWB:EZB	US
	Prismo Metals Inc OTC:PMOMF	CA
E	Enzo Biochem Inc LSE:0IHV	US
	Seacoast Banking Corporation of Florida F:SBG1	US
B	Bifire SpA F:Q8I	IT

Profitability Summary

Sea Mild Biotechnology Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

27%

Sustainable 3Y Average Gross Margin

26%

Gross Margin is Increasing

19% > 27%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

0% > 5%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

0% > 6%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

6% > 3%

Positive ROE

22%

Positive 3Y Average ROE

Positive 3Y Average ROIC

14%

ROIC is Increasing

-1% > 14%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.